Show simple item record

dc.contributor.authorMeylan, Etienne
dc.contributor.authorOliver, Trudy
dc.coverage.temporalFall 2009
dc.date.accessioned2023-03-06T17:03:35Z
dc.date.available2023-03-06T17:03:35Z
dc.date.issued2009-12
dc.identifier7.343-Fall2009
dc.identifier.other7.343
dc.identifier.otherIMSCP-MD5-5e9c061f020c0e162cc8be51e4e86da4
dc.identifier.urihttps://hdl.handle.net/1721.1/148336
dc.description.abstractDuring this course, we will study the similarities between cancer and normal development to understand how tumors co-opt normal developmental processes to facilitate cancer initiation, maintenance and progression. We will examine critical signaling pathways that govern these processes and, importantly, how some of these pathways hold promise as therapeutic targets for cancer treatment. We will discuss how future treatments might be personalized to target cancer cells in specific patients. We will also consider examples of newly-approved drugs that have dramatically helped patients combat this devastating disease. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching.en
dc.language.isoen-US
dc.rightsThis site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions.en
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Unported*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/*
dc.subjectcanceren
dc.subjectembryogenesisen
dc.subjectsonic hedgehogen
dc.subjecttumoren
dc.subjectsignalingen
dc.subjectproto-oncogeneen
dc.subjectKrasen
dc.subjectapoptosisen
dc.subjectself-renewalen
dc.subjectregenerationen
dc.subjectangiogenesisen
dc.subjectVEGFen
dc.subjecttumorigenesisen
dc.subjectmetastasisen
dc.subjectmicroRNAen
dc.title7.343 When Development Goes Awry: How Cancer Co-opts Mechanisms of Embryogensis, Fall 2009en
dc.title.alternativeWhen Development Goes Awry: How Cancer Co-opts Mechanisms of Embryogensisen
dc.typeLearning Object
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biology
dc.audience.educationlevelUndergraduate
dc.subject.cip260503en
dc.subject.cipMedical Microbiology and Bacteriologyen
dc.date.updated2023-03-06T17:03:41Z


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record